MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s13256-026-06256-9

Медицинская библиотека · Journal of medical case reports · 2026

Disseminated Ureaplasma urealyticum infection presenting as systemic inflammatory syndrome in ocrelizumab-treated patients with multiple sclerosis: a case series.

Witkowska Anna, Cahill Fionnuala, O'Rourke Killian, McGettrick Padraig, Burke Tomás, McCarthy Geraldine, Kitchen Joanne, Abuelmagd Abdalla, Stack John

СтатьяКлинический случайПеревод пока не подготовлен

Аннотация

BACKGROUND

Ocrelizumab, an anti-CD20 monoclonal antibody, is widely used to treat multiple sclerosis (MS), inducing profound B-cell depletion and disease remission. However, it may rarely lead to opportunistic infections. We report two patients with MS on ocrelizumab who developed unique complications of anti-CD20 antibody therapy. One patient developed fulminant endophthalmitis, a novel complication that has not been previously reported.

CASE PRESENTATION: A 38-year-old female of South Asian descent and a 46-year-old White female, both with MS on ocrelizumab, developed disseminated Ureaplasma urealyticum infection which was initially misdiagnosed as reactive arthritis in both cases. Both patients deteriorated following immunosuppression, with one developing fulminant endophthalmitis. Diagnosis was established via broad-range PCR from synovial and ocular samples. Prolonged antimicrobial and glucocorticoid therapy led to resolution in both cases.

CONCLUSIONS

Novel B-cell targeting agents can be effective treatments for MS; however, their use may be associated with potentially life-threatening complications. These two cases highlight the diagnostic and therapeutic challenges associated with opportunistic infections in the context of anti-CD20 monoclonal antibody therapy.

Для цитирования: Witkowska Anna, Cahill Fionnuala, O'Rourke Killian, McGettrick Padraig, Burke Tomás, McCarthy Geraldine, Kitchen Joanne, Abuelmagd Abdalla, Stack John. Disseminated Ureaplasma urealyticum infection presenting as systemic inflammatory syndrome in ocrelizumab-treated patients with multiple sclerosis: a case series.. Journal of medical case reports. 2026. DOI: 10.1186/s13256-026-06256-9.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.